Cephalon Submits Fentora sNDA For Chronic Pain
This article was originally published in The Pink Sheet Daily
Executive Summary
Application includes strengthened risk management plan to ensure appropriate patient use and dosing, a critical concern after deaths were reported following unapproved uses.